Intake of Bifidobacterium longum and Fructo-oligosaccharides prevents Colorectal Carcinogenesis

We aimed to investigate the effects of intake of yogurt containing (BB536-y) and fructo-oligosaccharides (FOS) in preventing colorectal carcinogenesis in healthy subjects, and the preventive effects of short-chain fatty acids (SCFA), whose production was enhanced by the intake of BB536-y and FOS, in...

Full description

Saved in:
Bibliographic Details
Published inEuroasian journal of hepato-gastroenterology Vol. 8; no. 1; pp. 11 - 17
Main Authors Ohara, Tadashi, Suzutani, Tatsuo
Format Journal Article
LanguageEnglish
Published India Jaypee Brothers Medical Publishers 01.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We aimed to investigate the effects of intake of yogurt containing (BB536-y) and fructo-oligosaccharides (FOS) in preventing colorectal carcinogenesis in healthy subjects, and the preventive effects of short-chain fatty acids (SCFA), whose production was enhanced by the intake of BB536-y and FOS, in human colon cancer cell lines. The subjects were 27 healthy persons who were divided into a group taking yogurt containing BB536 (BB536-y group; n = 14) and a group taking yogurt containing BB536 and FOS (BB536-y with FOS group; n = 13) once a day for 5 weeks. The feces were sampled before and after the intake to analyze the amount of SCFA in the feces and the profile of intestinal flora, such as putrefactive bacteria and enterotoxin (ETBF). Subsequently, human colon cancer cell lines (DLD-1 cells, WirDr cells) were cultured in the presence of SCFA (butyric acid, isobutyric acid, acetic acid) in order to evaluate the cell growth-inhibitory activity of SCFA (WST-8 assay) by calculating the IC value from the dose-response curve. Intake of BB536-y increased the total amount of SCFA in the feces and significantly suppressed the detection rate of ETBF and growth of putrefactive bacteria. Intake of BB536-y with FOS was associated with a higher detection rate than that of BB536-y alone. The contents of butyric acid, isobutyric acid, and acetic acid, namely, of SCFA, were also decreased. Analysis of the results of culture of DLD-1 cells and WirDr cells in the presence of butyric acid, isobutyric acid, and acetic acid revealed that each of the substances showed significant cell growth-inhibitory activity, with the activity being the highest for butyric acid, followed by that for isobutyric acid and acetic acid. These findings suggest that intake of both BB536-y and BB536-y with FOS prevents colorectal carcinogenesis. Ohara T, Suzutani T. Intake of and Fructo-oligosaccharides prevents Colorectal Carcinogenesis. Euroasian J Hepato-Gastroenterol 2018;8(1):11-17.
AbstractList We aimed to investigate the effects of intake of yogurt containing (BB536-y) and fructo-oligosaccharides (FOS) in preventing colorectal carcinogenesis in healthy subjects, and the preventive effects of short-chain fatty acids (SCFA), whose production was enhanced by the intake of BB536-y and FOS, in human colon cancer cell lines. The subjects were 27 healthy persons who were divided into a group taking yogurt containing BB536 (BB536-y group; n = 14) and a group taking yogurt containing BB536 and FOS (BB536-y with FOS group; n = 13) once a day for 5 weeks. The feces were sampled before and after the intake to analyze the amount of SCFA in the feces and the profile of intestinal flora, such as putrefactive bacteria and enterotoxin (ETBF). Subsequently, human colon cancer cell lines (DLD-1 cells, WirDr cells) were cultured in the presence of SCFA (butyric acid, isobutyric acid, acetic acid) in order to evaluate the cell growth-inhibitory activity of SCFA (WST-8 assay) by calculating the IC value from the dose-response curve. Intake of BB536-y increased the total amount of SCFA in the feces and significantly suppressed the detection rate of ETBF and growth of putrefactive bacteria. Intake of BB536-y with FOS was associated with a higher detection rate than that of BB536-y alone. The contents of butyric acid, isobutyric acid, and acetic acid, namely, of SCFA, were also decreased. Analysis of the results of culture of DLD-1 cells and WirDr cells in the presence of butyric acid, isobutyric acid, and acetic acid revealed that each of the substances showed significant cell growth-inhibitory activity, with the activity being the highest for butyric acid, followed by that for isobutyric acid and acetic acid. These findings suggest that intake of both BB536-y and BB536-y with FOS prevents colorectal carcinogenesis. Ohara T, Suzutani T. Intake of and Fructo-oligosaccharides prevents Colorectal Carcinogenesis. Euroasian J Hepato-Gastroenterol 2018;8(1):11-17.
We aimed to investigate the effects of intake of yogurt containing Bifidobacterium longum (BB536-y) and fructo-oligosaccharides (FOS) in preventing colorectal carcinogenesis in healthy subjects, and the preventive effects of short-chain fatty acids (SCFA), whose production was enhanced by the intake of BB536-y and FOS, in human colon cancer cell lines.INTRODUCTIONWe aimed to investigate the effects of intake of yogurt containing Bifidobacterium longum (BB536-y) and fructo-oligosaccharides (FOS) in preventing colorectal carcinogenesis in healthy subjects, and the preventive effects of short-chain fatty acids (SCFA), whose production was enhanced by the intake of BB536-y and FOS, in human colon cancer cell lines.The subjects were 27 healthy persons who were divided into a group taking yogurt containing BB536 (BB536-y group; n = 14) and a group taking yogurt containing BB536 and FOS (BB536-y with FOS group; n = 13) once a day for 5 weeks. The feces were sampled before and after the intake to analyze the amount of SCFA in the feces and the profile of intestinal flora, such as putrefactive bacteria and Bacteroides fragilis enterotoxin (ETBF). Subsequently, human colon cancer cell lines (DLD-1 cells, WirDr cells) were cultured in the presence of SCFA (butyric acid, isobutyric acid, acetic acid) in order to evaluate the cell growth-inhibitory activity of SCFA (WST-8 assay) by calculating the IC50 value from the dose-response curve.MATERIALS AND METHODSThe subjects were 27 healthy persons who were divided into a group taking yogurt containing BB536 (BB536-y group; n = 14) and a group taking yogurt containing BB536 and FOS (BB536-y with FOS group; n = 13) once a day for 5 weeks. The feces were sampled before and after the intake to analyze the amount of SCFA in the feces and the profile of intestinal flora, such as putrefactive bacteria and Bacteroides fragilis enterotoxin (ETBF). Subsequently, human colon cancer cell lines (DLD-1 cells, WirDr cells) were cultured in the presence of SCFA (butyric acid, isobutyric acid, acetic acid) in order to evaluate the cell growth-inhibitory activity of SCFA (WST-8 assay) by calculating the IC50 value from the dose-response curve.Intake of BB536-y increased the total amount of SCFA in the feces and significantly suppressed the detection rate of ETBF and growth of putrefactive bacteria. Intake of BB536-y with FOS was associated with a higher Bifidobacterium detection rate than that of BB536-y alone. The contents of butyric acid, isobutyric acid, and acetic acid, namely, of SCFA, were also decreased. Analysis of the results of culture of DLD-1 cells and WirDr cells in the presence of butyric acid, isobutyric acid, and acetic acid revealed that each of the substances showed significant cell growth-inhibitory activity, with the activity being the highest for butyric acid, followed by that for isobutyric acid and acetic acid.RESULTSIntake of BB536-y increased the total amount of SCFA in the feces and significantly suppressed the detection rate of ETBF and growth of putrefactive bacteria. Intake of BB536-y with FOS was associated with a higher Bifidobacterium detection rate than that of BB536-y alone. The contents of butyric acid, isobutyric acid, and acetic acid, namely, of SCFA, were also decreased. Analysis of the results of culture of DLD-1 cells and WirDr cells in the presence of butyric acid, isobutyric acid, and acetic acid revealed that each of the substances showed significant cell growth-inhibitory activity, with the activity being the highest for butyric acid, followed by that for isobutyric acid and acetic acid.These findings suggest that intake of both BB536-y and BB536-y with FOS prevents colorectal carcinogenesis.How to cite this article: Ohara T, Suzutani T. Intake of Bifidobacterium longum and Fructo-oligosaccharides prevents Colorectal Carcinogenesis. Euroasian J Hepato-Gastroenterol 2018;8(1):11-17.CONCLUSIONThese findings suggest that intake of both BB536-y and BB536-y with FOS prevents colorectal carcinogenesis.How to cite this article: Ohara T, Suzutani T. Intake of Bifidobacterium longum and Fructo-oligosaccharides prevents Colorectal Carcinogenesis. Euroasian J Hepato-Gastroenterol 2018;8(1):11-17.
Author Suzutani, Tatsuo
Ohara, Tadashi
Author_xml – sequence: 1
  givenname: Tadashi
  surname: Ohara
  fullname: Ohara, Tadashi
  organization: Department of Intestinal Bioscience and Medicine, Fukushima Medical University, Fukushima City, Fukushima, Japan
– sequence: 2
  givenname: Tatsuo
  surname: Suzutani
  fullname: Suzutani, Tatsuo
  organization: Department of Microbiology, Fukushima Medical University, Fukushima City, Fukushima, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29963455$$D View this record in MEDLINE/PubMed
BookMark eNpVUNFKwzAUDTJxc-4XRh99qSZpmiYvghang4Ev-lzSNO0y06Qm7cC_N-AUvQ_nXLj3nnO4l2BmnVUArBG8ySHMbw9DenCTt8KEFEGIWIpwjs7AAuMMpTnCbPbTQ1LMwSqEA4zFKEeouABzzDnNSJ4vQLW1o3hXiWuTB93qxtVCjsrrqU-Ms10kYZtk4yc5utQZ3bkgpNwLrxsVksGro7JjSEpnnFdyFCYphZfauk5ZFXS4AudtjKlWJ16Ct83ja_mc7l6etuX9Lh0QQjQljIlCkDbnhEagNZctxK3MCslxi2VNSUM4x0RkDCkWsW5YQRmRvKCKwGwJ7r51h6nuVSNjKi9MNXjdC_9ZOaGr_xOr91XnjhWFOJ7TKHB9EvDuY1JhrHodpDJGWOWmUGFIswLDjLO4uv7r9Wvy89XsC6iFgXM
ContentType Journal Article
Copyright Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd. 2018
Copyright_xml – notice: Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd. 2018
DBID NPM
7X8
5PM
DOI 10.5005/jp-journals-10018-1251
DatabaseName PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2231-5128
EndPage 17
ExternalDocumentID PMC6024036
29963455
Genre Journal Article
GroupedDBID ACZLU
ADBBV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
EMOBN
HYE
NPM
OK1
PW6
RPM
7X8
5PM
ID FETCH-LOGICAL-p1116-488a7a4f5946f596b9cf02fc37c92f2cb64d49924a381e8a38bd87684c976e403
ISSN 2231-5047
IngestDate Thu Aug 21 14:08:02 EDT 2025
Fri Jul 11 03:27:08 EDT 2025
Thu Jan 02 22:28:32 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 1
Keywords Probiotics
Short-chain fatty acids
Intestinal microbiome
Colorectal carcinoma
Gastroenterology
Prebiotics
Language English
License This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p1116-488a7a4f5946f596b9cf02fc37c92f2cb64d49924a381e8a38bd87684c976e403
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC6024036
PMID 29963455
PQID 2063720398
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6024036
proquest_miscellaneous_2063720398
pubmed_primary_29963455
PublicationCentury 2000
PublicationDate 2018 Jan-Jun
20180101
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018 Jan-Jun
PublicationDecade 2010
PublicationPlace India
PublicationPlace_xml – name: India
PublicationTitle Euroasian journal of hepato-gastroenterology
PublicationTitleAlternate Euroasian J Hepatogastroenterol
PublicationYear 2018
Publisher Jaypee Brothers Medical Publishers
Publisher_xml – name: Jaypee Brothers Medical Publishers
SSID ssj0000869117
Score 2.0143948
Snippet We aimed to investigate the effects of intake of yogurt containing (BB536-y) and fructo-oligosaccharides (FOS) in preventing colorectal carcinogenesis in...
We aimed to investigate the effects of intake of yogurt containing Bifidobacterium longum (BB536-y) and fructo-oligosaccharides (FOS) in preventing colorectal...
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 11
SubjectTerms Original
Title Intake of Bifidobacterium longum and Fructo-oligosaccharides prevents Colorectal Carcinogenesis
URI https://www.ncbi.nlm.nih.gov/pubmed/29963455
https://www.proquest.com/docview/2063720398
https://pubmed.ncbi.nlm.nih.gov/PMC6024036
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagXLggEK_lJSNxQ4Zs4jjOESqqwgEurdRbZDvxNqKNV5uEQ389M_ZmNwlbCbhYqyRrWZ4v83LmG0LeaQ12TvOYRVYaxqWwTJZVxHia2NQoCzbffyD7XZye828X6cW-K6qvLun0B3NzsK7kf6QK10CuWCX7D5LdTQoX4DfIF0aQMIx_JeOvTad--qD_c23rEl5NT73cX7-_cs2qD90vTpAg1jF3Va9cqwyWWdVl1SI7wC9f3nYM-g_1HqYRsLNQ41aoAOt2nrUPBZcjrolLsGUw9Uq13cYhuedmkqT_gWTQHhCqxJ5N-wOom74LvaTgVtf2bpx7WMpR7sGrKPAtliyNAmfmoE_lH7AJujEo1bnKTkENoMpes-3yW4a0UBDaxunkD7D162svSLCgIuGB3XdGlj3cukvuxRA3xKP0jTfNUoByxxL63cpD1Tiu4uPhNSBd9HbWQ1HI_GPakXdy9pA82IYV9FPAyCNyp2oekyLggzpLZ_igAR8U8EFvwQcd8EH3-KBTfDwh5ydfzo5P2bahBluDSRPwKkqVKW7TnAsYhM6NjWJrkszksY2NFryECDjmCvy4SsKoS4kntQac1opHyVNy1Limek6o0vHS6DKPIiO51JXOpDXaRpVOjVZptiBvh60qQGHhKZRqKte3RQxOMZ7953JBnoWtK9aBWaUYNnpBssmm7h5AMvTpnaa-9KToAsn6EvHi1jlfkvt7CL8iR92mr16DQ9npNx4kvwGUmH3j
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intake+of+Bifidobacterium+longum+and+Fructo-oligosaccharides+prevents+Colorectal+Carcinogenesis&rft.jtitle=Euroasian+journal+of+hepato-gastroenterology&rft.au=Ohara%2C+Tadashi&rft.au=Suzutani%2C+Tatsuo&rft.date=2018-01-01&rft.issn=2231-5047&rft.volume=8&rft.issue=1&rft.spage=11&rft_id=info:doi/10.5005%2Fjp-journals-10018-1251&rft_id=info%3Apmid%2F29963455&rft.externalDocID=29963455
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2231-5047&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2231-5047&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2231-5047&client=summon